Clinical Report: Relevance, Relationships, Research – Riva!

Overview

The Riva meeting serves as a pivotal forum for advancing separation science, particularly in chromatography. It fosters collaboration and innovation among researchers and instrument developers, highlighting the importance of face-to-face scientific exchanges.

Background

The Riva meeting, an evolution of the International Symposium on Capillary Chromatography, plays a crucial role in the development of separation science. It provides a platform for presenting emerging technologies and fostering dialogue among experts. The meeting's historical significance and ongoing relevance underscore its impact on research and clinical applications.

Data Highlights

No numerical data available in the source material.

Key Findings

• Riva has evolved to include significant advancements in capillary electrophoresis and GC×GC technologies.
• The meeting has grown from 100 registrants to over 300 participants in the GC×GC section prior to the pandemic.
• Key figures like Pat Sandra and Luigi Mondello have shaped the direction and growth of the Riva conference.
• Riva emphasizes the importance of presenting new research while also considering historical perspectives in chromatography.
• Innovative ideas, such as cryogenic modulation, have emerged from discussions at Riva, influencing the field of gas chromatography.

Clinical Implications

The advancements discussed at Riva have direct implications for clinical assays and therapeutic monitoring, particularly in endocrinology and toxicology. High-specificity chromatographic methods are essential for accurate biochemical measurements that guide treatment decisions.

Conclusion

The Riva meeting continues to be a cornerstone for innovation in separation science, bridging the gap between research and clinical application. Its focus on collaboration and emerging technologies is vital for the future of chromatography.

References

1. Drugs - Real World Outcomes, Springer, 2019 -- RWE Framework: A Dynamic Visual Resource for Designing Real-World Evidence Studies
2. Drug Safety, Springer, 2024 -- Updated Reporting Guidelines for Evaluating Pharmaceutical Risk Minimization Studies: An Extension of the Standards for Implementation Study Reporting (RIMES-SE)
3. ADA News, ADA, 2021 -- ADA Science & Research Institute’s mission helps the dentists of today and tomorrow
4. Drugs - Real World Outcomes, Springer, 2021 -- Overview, Obstacles, and Future Insights on Real-World Data and Evidence in Japan
5. Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology & Metabolism, 2025
6. Measurement of Whole Blood Tacrolimus Concentrations by LC-MS/MS and Immunoassay Methods, The Journal of Applied Laboratory Medicine, 2025
7. Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline | The Journal of Clinical Endocrinology & Metabolism | Oxford Academic
8. Measurement of Whole Blood Tacrolimus Concentrations by LC-MS/MS and Immunoassay Methods: Influence of Immediate-Release vs Extended-Release Tacrolimus Formulations | The Journal of Applied Laboratory Medicine | Oxford Academic
9. Determination of lung cancer exhaled breath biomarkers using machine learning-a new analysis framework | Scientific Reports